Lumida
/ARQ
⌘K
Arq Inc

Arq Inc

ARQ
$2.17USD-1.81%-0.04 today

MARKET CAP

94.8M

P/E (TTM)

FWD P/E

DAY RANGE

$2 – $2

52W RANGE

$2
$8

AI Summary

Stalk
StalkMedium

ARQ remains in a Stage 2 advance with medium-term bullish structure but recent weakness into flat short-term EMAs and high Stage Transition Risk suggests deferred entries. A speculative bias favors waiting for a pullback into rising EMAs or the prior consolidation range for evidence of absorption before commitment.

  • Launch of PAC for PFAS aligns ARQ with growing remediation market by 2027.
  • Q2 revenue up 5% YoY to $29.9M; gross margin expanded to 38.5%.
  • Full-year net loss of $52M and negative earnings yield highlight unprofitability.
Full analysis →

Buying

6

institutions

Selling

2

institutions

New Positions

2

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
AC

Aqr Capital Management LLC

Q2 2026

BUY1.81 M4.63 M+728.40 K+66.4%0.00%
RT

Renaissance Technologies LLC

Q2 2026

BUY598.06 K1.53 M+187.49 K+45.1%0.00%
BI

Blackrock, Inc.

Q2 2026

SELL508.96 K1.30 M+-1.59 M-75.8%0.00%
CA

Citadel Advisors LLC

Q2 2026

BUY235.80 K601.29 K+224.70 K+2016.0%0.00%
MG

Man Group Plc

Q2 2026

BUYNEW58.95 K150.33 K+58.95 K+0.0%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

BUYNEW57.58 K146.83 K+57.58 K+0.0%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

BUY37.62 K94.06 K+20.06 K+115.1%0.00%
MM

Millennium Management LLC

Q2 2026

SELL19.02 K48.49 K+-26.50 K-58.4%0.00%